Back to Industry-Wide News
Dear Friend and Customer,
Hoping you, your family, and colleagues are all doing well,
In light of the increasing spread and ongoing efforts to combat COVID-19, the USTR has determined that maintaining additional tariffs on certain health care products subject to Section 301 action is no longer appropriate, and that the application of additional duties to these products could affect the U.S. to address COVID-19.
These exclusions will apply from January 1, 2021 through March 31, 2021. Certain product exclusions that were initially scheduled to expire on December 31, 2020 will run through March 31, 2021.
Please review the full rule and list of products: 85 FR 85831.
Do not hesitate to contact us if you have any comments or questions.